Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.
about
The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy.PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive AgentsAnti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia CellsBeyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.
P2860
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Profile of sapacitabine: poten ...... leukemia in elderly patients.
@en
type
label
Profile of sapacitabine: poten ...... leukemia in elderly patients.
@en
prefLabel
Profile of sapacitabine: poten ...... leukemia in elderly patients.
@en
P2860
P356
P1476
Profile of sapacitabine: poten ...... leukemia in elderly patients.
@en
P2093
Katarzyna Jamieson
P2860
P304
P356
10.2147/CIA.S39558
P407
P50
P5008
P577
2014-05-06T00:00:00Z